Skip to main content
. 2015 Feb 10;20(3):323–328. doi: 10.1634/theoncologist.2014-0420

Figure 1.

Figure 1.

Duration of response in 16 patients with relapsed or refractory classical Hodgkin lymphoma who received brentuximab vedotin.

Abbreviations: CR, complete remission; GVHD, graft-versus-host disease; haplo-SCT, haploidentical stem cell transplant; PD, progressive disease; PR, partial remission; SD, stable disease.